2YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Palmitoyl Tetrapeptide-7 | 棕榈酰四肽-7 | 221227-05-0 |
| p-NCS-Bn-DOTA | 2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 | 127985-74-4 |
| DOTA-mono-NHStris(t-Buester) | DOTA-三叔丁酯-琥珀酰亚胺酯 | 819869-77-7 |
| pasireotide | 帕瑞肽 | 396091-73-9 |
| Octreotide | 奥曲肽 | 79517-01-4 |
| Oligonucleotide Synthesis | 寡合苷酸合成 | 4097-22-7 |
| 2'-F-iBu-dG-CE-Phosphoramidite; 2'-fluoro-N2-isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine-3'-CE-Phosphoramidite | 2'-F-dG(iBu) 亚磷酰胺单体 | 144089-97-4 |
| Maleimido-mono-amide-DOTA | 1006711-90-5 | |
| Angiotensin II (1-4), human | 血管紧张素II | 4474-91-3 |
| Fmoc-Gln(Trt)-Thr(Psi(Me,Me)pro)-OH | (4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,5-二氧代-5-[(三苯基甲基)氨基]戊基]-2,2,5-三甲基-4-恶唑烷羧酸 | 1572725-72-4 |
| Oxytocin Acetate | 催产素 | 50-56-6 |
| Eptifibatide | 依替巴肽 | 188627-80-7 |
| Peptide fluorescent modification | 多肽荧光修饰 | |
| Copper Peptide | 三胜肽 | 49557-75-7 |
| Fmoc-Phe-Val-Gln(Trt)-Trp(Boc)-Leu-Ile-Ala-Gly | ||
| c(RGDfK) | CYCLO (RGDFK) | 161552-03-0 |
| 5'-O-(4,4-Dimethoxytrityl)-2'-O-methyl-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | 5'-O-(4,4-二甲氧基三苯甲基)-2'-O-甲基-N-异丁酰基鸟苷-3'-(2-氰基乙基-N,N-二异丙基)亚磷酰胺 | 150780-67-9 |
| Fmoc-Asp(tBu)-Thr[PSI(Me,Me)Pro]-OH | (BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2,5-三甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯 | 920519-32-0 |
| Myristoyl Tetrapeptide-12 | 肉豆蔻酰四肽-12 | 959610-24-3 |
| Biotinoyl tripeptide-1 | 生物素酰三肽-1 | 299157-54-3 |
| 2'-F-Bz-dA-CE-Phosphoramidite; 2'-fluoro-N6-benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine-3'-CE-Phosphoramidite | N6-苯甲酰基5'-O-DMT-2'-氟-脱氧腺苷-3'-氰乙氧基亚磷酰胺 | 136834-22-5 |
| Icatibant | 艾替班特 | 30308-48-4 |
| Human GLP-1 (7-36)-NH2 | 胰高血糖素样肽1(7-36)酰胺(人) | 107444-51-9 |
| Fmoc-Ile-Ser[PSI(Me,Me)Pro]-OH | (4S)-3-[(2S,3S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代戊基]-2,2-二甲基-4-恶唑烷羧酸 | 1147996-34-6 |
| GLP-1(7-37) | 人胰高血糖素样肽-1 | 106612-94-6 |
| Peptide customization | 多肽定制 | |
| DOTA-tris(tBuester) | 三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 | 137076-54-1 |
| Nesiritide | 奈西利肽 | 124584-08-3 |
| BocNH-Tyr(tBu)-Aib-Glu(OtBu)-Gly-Thr(tBu)-Phe-Thr(tBu)-Ser(tBu)-Asp(OtBu)-Tyr(tBu)-Ser(tBu)-Ile-Aib-Leu | ||
| White powder | 碳酸钙 | 471-34-1 |
| CNV-38d(1-34) | 醋酸特立帕肽 | 52232-67-4 |
| Triptorelin Acetate | 醋酸曲普瑞林 | 57773-63-4 |
| Tirzepatide | 新型双重GIP\GLP-1 | 2023788-19-2 |
| Fmoc-Val-Thr[PSI(Me,Me)Pro]-OH | (4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代丁基]-2,2,5-三甲基-4-恶唑烷羧酸 | 168216-05-5 |
| DOTA-NHS-ester | 易吸潮 | 1823122-52-6 |
| Fmoc-Tyr(tBu)-Thr[PSI(Me,Me)Pro]-OH | (4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-恶唑烷羧酸 | 920519-31-9 |
| Fmoc-Leu-Thr[PSI(Me,Me)Pro]-OH | (5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸 | 955048-89-2 |
| Ziconotide acetate | 齐考诺肽 | 107452-89-1 |
| 2'-F-Bz-dC-CE-Phosphoramidite; N4-benzoyl-5'-O-(4, 4'-dimethoxytrityl)-2'-fluoro-2'-deoxycytidine-3'-CE-Phosphoramidite | N4-苯甲酰基-5'-O-DMT-2'-氟-脱氧胞苷-3'-氰乙氧基亚磷酰胺 | 161442-19-9 |
| Fmoc-Ile-Thr[PSI(Me,Me)Pro]-OH | (5R)-3-[(2S,3S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸 | 957780-52-8 |
| Fmoc-Thr(tBu)-Ser(Psi(Me,Me)pro)-OH | (4S)-3-[(2S,3R)-3-(叔丁氧基)-2-[[芴甲氧羰基]氨基]-1-氧代丁基]-2,2-二甲基-4-恶唑烷羧酸 | 1425938-63-1 |
| Fmoc-Tyr(tBu)-Ser[PSI(Me,Me)Pro]-OH | (4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 | 878797-09-2 |
| Fmoc-Trp(Boc)-Thr[PSI(Me,Me)Pro]-OH | (5R)-3-[(2S)-3-[1-[叔丁氧羰基]-1H-吲哚-3-基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-恶唑烷羧酸 | 936707-21-0 |
| Glucagon HCL | 盐酸胰高血糖素 | 11140-85-5 |
| polypeptide | 多肽定制、多肽合成 | |
| Fmoc-Gly-Ser[PSI(Me,Me)Pro]-OH | (4S)-3-[2-[[芴甲氧羰基]氨基]乙酰基]-2,2-二甲基-4-恶唑烷羧酸 | 1095952-22-9 |
| Fmoc-Phe-Ser[PSI(Me,Me)Pro]-OH | (4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1-氧代-3-苯基丙基]-2,2-二甲基-4-恶唑烷羧酸 | 878797-01-4 |
| 2'-F-dU-CE-Phosphoramidite | ||
| Acetyl Tetrapeptide-5 | 乙酰基四肽-5 | 820959-17-9 |
| Goserelin | 戈舍瑞林 | 65807-02-5 |
| Myristoyl Pentapeptide-17 | 睫毛肽 | 959610-30-1 |
| Morpholino T subunit; 6-(5-methyl-2, 4-dioxo-3, 4-dihydropyrimidin-1(2H)-yl)-4-ritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate | N,N-二甲基氯亚膦酰胺 [(2S,6R)-6-(3,4-二氢-5-甲基-2,4-二氧代-1(2H)-嘧啶基)-4-(三苯基甲基)-2-吗啉基]甲基酯 | 956139-30-3 |
| Amyloid β-Protein(16-22) | Amyloid β-Protein(16-22) | 153247-41-7 |
| Adrenomedullin (1-52), human | Adrenomedullin (human) | 148498-78-6 |
| Pramlintide acetate | 醋酸普兰林肽 | 196078-30-5 |
| NOTA-bis(t-Buester) | NOTA-BIS(叔丁基酯) | 1161415-28-6 |
| Fmoc-Asn(Trt)-Ser[PSI(Me,Me)Pro]-OH | (4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2-二甲基-4-恶唑烷羧酸 | 920519-33-1 |
| Exenatide acetate | 醋酸艾塞那肽 | 141732-76-5 |
| Palmitoyl Pentapeptide-4 | 五胜肽 | 214047-00-4 |
| Morpholino U subunit | ||
| Oligonucleotide customization | 寡核苷酸定制 | |
| BocNH-Tyr(tBu)-Aib-Glu(OtBu)-Gly | ||
| Glucagon - Like Peptide 1, (GLP-1/GLP1) amide, human | 胰高血糖素样肽1酰胺(人) | 99658-04-5 |
| Fmoc-Ala-Ser[PSI(Me,Me)Pro]-OH | (4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 | 252554-78-2 |
| Angiotensin Converting Enzyme Inhibitor | 替普罗肽 | 35115-60-7 |
| Morpholino C subunit; 6-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl Dimethylphosphoramidochloridate | 956139-21-2 | |
| Myristoyl-Hexapeptide-16 | 肉蔻酰六胜肽-16 | 959610-54-9 |
| Fmoc-Gln(Trt)-Ser[PSI(Me,Me)Pro]-OH | FMOC-GLN(TRT)-SER(PSI(ME,ME)PRO)-OH | 1821378-64-6 |
| DOTAGA-tetra(tBuester) | DOTAGA-四叔丁酯 | 306776-79-4 |
| Fmoc-Leu-Ser[PSI(Me,Me)Pro]-OH | (4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2-二甲基-4-恶唑烷羧酸 | 339531-50-9 |
| 5'-O-(4,4-Dimethoxytrityl)-2'-O-methyluridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | 2'-OMe-U 亚磷酰胺单体 | 110764-79-9 |
| Ganirelix | 加尼瑞克 | 123246-29-7 |
| Custom Peptide | 客户肽；定制肽；科研肽；多肽定制；多肽合成 | |
| Fmoc-Phe-Thr[PSI(Me,Me)Pro]-OH | (4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1-氧代-3-苯基丙基]-2,2,5-三甲基-4-恶唑烷羧酸 | 1196703-48-6 |
| Katacalcin | 钙抑肽 | 85916-47-8 |
| Glucagon | 胰高血糖素 | 16941-32-5 |
| 4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-6-[3-(1-piperazinyl)propoxy]- | FAPI | 2471983-20-5 |
| Leuprorelin | 亮丙瑞林 | 74381-53-6 |
| Acetyl tetrapeptide-3 | 乙酰基四肽-3;促眉肽 | 827306-88-7 |
| Morpholino A subunit; (6-(6-benzamido-9H-purin-9-yl)-4-tritylmorpholin-2-yl) methyl dimethylphosphoramidochloridate | N,N-二甲基氯亚膦酰胺 [(2S,6R)-6-[6-(苯甲酰基氨基)-9H-嘌呤-9-基]-4-(三苯基甲基)-2-吗啉基]甲基酯 | 956139-18-7 |
| GLP-2, human | 人胰高血糖素样肽2 | 99120-49-7 |
| Enfuvirtide | 恩夫韦肽 | 159519-65-0 |
| Fmoc-Ala-Thr[PSI(Me,Me)Pro]-OH | (4S,5R)-3-(N-芴甲氧羰基丙氨酰)-2,2,5-三甲基恶唑烷-4-羧酸 | 252554-79-3 |
| Peptide synthesis service | 多肽合成服务 | |
| DOTAM-mono-acid | DOTAM-MONO-羧酸试剂;4,7,10-三(2-氨基-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1-乙酸; | 913528-04-8 |
| Antide | 安替肽 | 112568-12-4 |
| Thymosin alpha 1 | 胸腺肽α1 | 62304-98-7 |
| Pal-Tripeptide-1 | 棕榈酰三肽-1 | 147732-56-7 |
| Morpholino G subunit | ||
| DOTAM-NHS-ester | 2236057-47-7 | |
| Fmoc-Asp(OtBu)-Lys(Boc)-Ile-Ala-Gln(Trt)-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-Ala | ||
| 2'-OMe-Bz-C-CE-Phosphoramidite; N4-benzoyl-5'-O-(4,4'-Dimethoxytrityl)-2'-O-methyl-Cytidine-3'-CE-Phosphoramidite | 2'-OMe-Bz-C 亚磷酰胺单体 | 110764-78-8 |
| Syn-AKE | 类蛇毒三肽 | 823202-99-9 |
| Leuprolide | 醋酸亮丙瑞林 | 53714-56-0 |
| Maleimido-mono-amide-NOTA | Maleimido-mono-amide-NOTA | 1295584-83-6 |
| H2N-Gly-Pro-Ser(tBu)-S(tBu)-Gly-Ala-Pro-Pro-Pro-S(tBu)-CONH2 | ||
| 2'-O-Methyl-rA(N-Bz)phosphoramidite | 2'-OMe-A(Bz) 亚磷酰胺单体;N-苯甲酰基-5'-O-(4,4-二甲氧基三苯甲基)-2'-O-甲基腺苷-3'-(2-氰基乙基-N,N-二异丙基)亚磷酰胺 | 110782-31-5 |
| Fmoc-Val-Ser[PSI(Me,Me)Pro]-OH | (4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代丁基]-2,2-二甲基-4-恶唑烷羧酸 | 186023-49-4 |
| NOTAGA-tris(t-Buester) | (R)-NODA-GA(tBu)3 | 438553-50-3 |
| (S)-6-[3-(4-Boc-1-piperazinyl)propoxy]-N-[2-(2-cyano-4,4-difluoro-1-pyrrolidinyl)-2-oxoethyl]quinoline-4-carboxamide | (S)-6-[3-(4-Boc-1-哌嗪基)丙氧基]-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺 | 2374782-82-6 |
| Fmoc-Lys(Boc)-Ser[PSI(Me,Me)Pro]-OH | (4S)-3-[(2S)-6-[[叔丁氧羰基]氨基]-2-[[芴甲氧羰基]氨基]-1-氧代己基]-2,2-二甲基-4-恶唑烷羧酸 | 957780-54-0 |
联系方式
